Research
Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials
Cite this as:
BMJ
2012;344:d7771
Related articles
Published 28 February 2012; BMJ 344 doi: 10.1136/bmj.e1459
Published 28 February 2012; BMJ 344 doi: 10.1136/bmj.e1451
Published 28 February 2012; BMJ 344 doi: 10.1136/bmj.e1455
Editorial: Glucagon-like peptide-1 agonists
Published 11 January 2012; BMJ 344 doi: 10.1136/bmj.d7282
Published 13 March 2008; BMJ 336 doi: 10.1136/bmj.39465.451748.AD
Published 6 December 2007; BMJ 335 doi: 10.1136/bmj.39385.413113.25
Published 16 November 2007; BMJ doi: 10.1136/bmj.39385.413113.25
See more
Published 19 June 2013; BMJ 346 doi: 10.1136/bmj.f3949
Published 19 June 2013; BMJ 346 doi: 10.1136/bmj.f3991
Published 18 June 2013; BMJ 346 doi: 10.1136/bmj.f3962
Published 18 June 2013; BMJ 346 doi: 10.1136/bmj.f3897
Published 18 June 2013; BMJ 346 doi: 10.1136/bmj.f3930
This article has been cited by other articles:








Social bookmarking